Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. - Wikidata - awgldk - TriplyDB

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

http://www.wikidata.org/entity/Q44385945

about

Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains Nonalcoholic fatty liver disease Non-alcoholic fatty liver disease: what the clinician needs to know.Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management Redox mechanisms in hepatic chronic wound healing and fibrogenesis Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?Comorbidities and Metabolic Derangement of NAFLD Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease Alanine aminotransferase-old biomarker and new concept: a review Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?Treatment of nonalcoholic steatohepatitis in adults: present and future Fatty liver disease in diabetes mellitus Fructose as a key player in the development of fatty liver disease Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease Obesity-Related Digestive Diseases and Their Pathophysiology Nonalcoholic fatty liver disease - A multisystem disease?Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?Metformin and metabolic diseases: a focus on hepatic aspects Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis Per-Arnt-Sim Kinase (PASK): An Emerging Regulator of Mammalian Glucose and Lipid Metabolism Systematic review: Preventive and therapeutic applications of metformin in liver disease Recent advances in understanding/management of non-alcoholic steatohepatitis.Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies Non-alcoholic fatty liver disease: need for a balanced nutritional source Epidemiology of the metabolic syndrome in the USA Inflammasomes and metabolic disorders: old genes in modern diseases High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates Menin prevents liver steatosis through co-activation of peroxisome proliferator-activated receptor alpha

P2860

Q21245690-7B2CCB64-6CF4-42BB-8751-56AA6646E04D Q21559453-3F6B3D27-4393-48E7-9514-3A4F241B8006 Q24555779-B38D6732-3305-4840-A5D4-DCF5AA0D7C9A Q24563068-10FA6F91-AFC5-4A00-8C8C-D7752515683A Q24631619-82537DFA-99A1-48DB-BE20-B9D2FBE54F5C Q24649618-E40ED956-E8A9-42C6-BCB1-9AA057B6D932 Q24656684-8E490A6C-B457-4666-944F-9C1610FE7550 Q26738646-D669EEFF-CE2E-4950-8FDE-3B52DEAC09BE Q26750955-321B6488-4C6C-40F4-987E-9A8DE0D45074 Q26752487-CB53D3FD-00D4-40F0-8329-59B9EF6A1CB8 Q26765455-AAAF5897-E68C-4637-BEDE-CD71E3EE249A Q26776043-74DFDC45-57D2-4F8B-A571-BBC97B6B1896 Q26777147-15A9EFEC-3EF4-48E9-BA66-0AEE713700F5 Q26781477-06FFB1E7-7F3F-4900-B4B3-ECF97BB1D55F Q26796448-1A9F836C-05B3-4152-B3BF-2C9A448A690E Q26824893-40ABF653-AD26-4E18-AC9C-DD82603FD413 Q26827665-5859610B-7A2D-442E-8734-6C49BFE21D15 Q26828819-D190620E-3BC9-4C21-9986-E3EC9FF4192D Q26828855-5BA69E3E-0C4A-4043-B2A4-5F22D9784FA4 Q26829503-9745AF17-AA7D-44F6-B834-4D42D78ED76C Q26852403-1F3DEB11-6634-44BA-9C92-7EF608F1FCA1 Q26996360-E7B8FC61-E898-498B-B19F-7FE867424B1B Q27014596-2F7C3750-1C96-4205-867B-9B731AB8D6AE Q27481042-C9ED8250-7648-46CA-895F-233A84D56D76 Q28073381-EE16B5A2-C5CD-4A87-AE71-9BBB9D178D47 Q28079077-BBE8C98E-58FC-420F-B5B6-217D747B2672 Q28079445-4D29A7B5-6133-4028-8E1C-0F8C6B3D2559 Q28082736-D64F5B43-36A6-4FEC-ACC1-F62F689297D8 Q28084150-78646BB0-5189-415A-8F25-8570161A5EC0 Q28085060-EDD50989-ECA8-41B8-9E53-95A865EC8A10 Q28085535-CC2982FC-8635-4BBE-ACC1-C4C9C31327DB Q28085689-11F9A96E-62C1-408F-91B1-E3521636417B Q28088325-FCC415F1-78B6-48A0-A1A2-7EF4401EA166 Q28248994-278F6B86-0B19-40F3-A440-E43AA71ED4C6 Q28298801-D89787EE-8737-4665-B20F-125EBC3B70DA Q28389531-A1AEC8C0-FF1D-4FBD-A24C-17E4924FB0D1 Q28474831-BE2ABE19-4828-4300-BDB3-E50461ED35C4 Q28476015-B08ECACC-4817-4726-B5E2-245A911FD646 Q28478084-3298D16D-16BA-4818-8169-2716F181CE86 Q28508425-654F0A2D-92DF-41F1-B193-D9F6E6995609

P2860

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

http://www.wikidata.org/entity/Q44385945

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

@en

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

@nl

type

label

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

@en

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

@nl

prefLabel

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

@en

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

@nl

P1433

Q44385945-BFADBF9F-3C76-4DFE-A624-88F6709A9B59

P1476

Q44385945-1E09D0FC-3495-4DBB-A6C2-367433FDDC14

P2093

Q44385945-12E22E27-D488-43B0-859E-4E4D7C15B10A

Q44385945-32CED6D6-75CC-4446-A33C-943FF6168CC2

Q44385945-60D25968-DD96-43C5-8F39-62F10B4F56DC

Q44385945-7C48C929-8E56-4DF4-AED1-105EBC25F0BB

Q44385945-BB2D1A4B-063B-48F9-A56C-128DED706B71

Q44385945-C89C7348-DE66-4543-ADFA-4C3A4A2F10C0

Q44385945-D5E78B57-C275-467A-9ABD-5EA6D34A790F

Q44385945-DD84BFC7-9BA7-4AD5-BEE8-A92207824F6C

Q44385945-EC0ACA96-DEFB-4A78-8A68-15B85E8192A0

P304

Q44385945-382EA9FD-D391-42F7-B65B-65C56A2A42F4

P31

Q44385945-EB93C7B5-D662-493C-85F2-37D63A6F54CE

P356

Q44385945-AC0ED4C2-0E35-482B-A575-BBD9618A4BA2

P407

Q44385945-5E0E4794-5A85-4298-9227-D31F20264D64

P433

Q44385945-D7A2409E-EBCB-4006-ADDA-272E82025A9F

P478

Q44385945-F2DB711D-B061-4EB7-AE19-7661C1DA35D9

P50

Q44385945-CDB1696F-EE5A-44F5-BADE-1CAB752EB47F

Q44385945-E514F893-612C-45AC-BFDE-5A9BECD5A00F

P577

Q44385945-0829100E-89B5-49AB-BBCB-A81BBF5F6A6B

P5875

Q44385945-94256139-69DE-44D4-9C50-6B92A753C65A

P698

Q44385945-146E4250-C438-41AA-B905-671F8FF10828

P921

Q44385945-2FC5546B-3260-48FF-BD18-C3CD85F5D1C3

Q44385945-F5E8D59E-8437-42FC-92DE-A00008288E62

P356

JHEP.2003.50161

P1433

P1476

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

@en

P2093

Ester Vanni

http://www.w3.org/2001/XMLSchema#string

Fernanda Cerrelli

http://www.w3.org/2001/XMLSchema#string

Gabriele Forlani

http://www.w3.org/2001/XMLSchema#string

Marco Lenzi

http://www.w3.org/2001/XMLSchema#string

Mario Rizzetto

http://www.w3.org/2001/XMLSchema#string

Nazario Melchionda

http://www.w3.org/2001/XMLSchema#string

Nicola Villanova

http://www.w3.org/2001/XMLSchema#string

Rita Manini

http://www.w3.org/2001/XMLSchema#string

Stefania Natale

http://www.w3.org/2001/XMLSchema#string

P304

917-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JHEP.2003.50161

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Giulio Marchesini

Elisabetta Bugianesi

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7706622

http://www.w3.org/2001/XMLSchema#string

P698

12668987

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

metabolic syndrome